STAT Diagnostica, a Barcelona, Spain-based company that focuses on the development of Point of Care diagnostic solutions for clinical applications, has raised €2m in Series A funding.
The round was led by Ysios Capital Partners, with participation from the venture fund from Instituto de Crédito Oficial (ICO) FESpyme FCR, managed by Axis Participaciones Empresariales.
The company intends to use the funds to develop its in-vitro Point of Care diagnostics platform, which can perform both molecular diagnostics and immunoassay. Its main applications will be in the fields of infectious diseases, antibiotic resistances and measuring biomarkers in critical patients or urgent situations.
Founded in 2010, STAT Diagnostica is based at Barcelona Science Park and is led by Managing Director Jordi Carrera.